A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson's disease.

ABSTRACT:

Background

Impulse control disorders are detrimental neuropsychiatric symptoms of Parkinson's disease. Increased impulsivity is a predisposing factor for impulse control disorders and should therefore be controlled. Recently, mindfulness meditation as a non-drug therapy has been reported to be useful in improving neuropsychiatric symptoms, such as impulsivity.

Methods

We performed a prospective single-arm, open-label pilot trial to investigate the effectiveness of mindfulness meditation to control impulsivity in patients with Parkinson's disease (UMIN clinical trials registry: UMIN000037779).

Results

Twenty patients with Parkinson's disease were enrolled in an 8-week mindfulness meditation program. As a primary outcome, we investigated whether the score of the Barratt

SUBMITTER: Koh J 

PROVIDER: S-EPMC8985985 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature